FeesSafety
Pluang+

Versant beats Q3 earnings estimates, grows digital revenue, and confirms full-year outlook.

Company Fundamentals
03 Nov 2026, 14:00 WIB
CNBC
View Source
Bullish
Versant beats Q3 earnings estimates, grows digital revenue, and confirms full-year outlook.

Versant Media reported third-quarter earnings that exceeded Wall Street expectations, driven by nearly 10% growth in digital platform revenue including Fandango. Despite a 5.3% decline in advertising revenue due to last year's Ryder Cup, the company reaffirmed its full-year 2026 revenue guidance of $6.2 to $6.45 billion and adjusted EBITDA between $1.9 and $2.05 billion. Versant's CEO highlighted growth in direct-to-consumer products and live sports viewership, with networks reaching over 120 million viewers monthly. The company also announced a $100 million accelerated stock repurchase program to be completed in Q4.

Versant earnings beat expectations, with Pluang's Media sector data providing market context as of Nov 03, 2026 15:51 WIB: Among 57 priced US Media stocks, 28 rose and 26 fell. Notable movers include BCE Inc. Common Stock at USD 20.66 with a 1-day change of +1.37%, New York Times Co at USD 69.33 down 1.21%, and Millicom International Cellular S.A. at USD 78.61 down 1.21%.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App